Drug Born at Duke Improves Survival in People with Advanced Brain Cancer
Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology created BMX-001, which has improved survival and lessened cognitive decline for people with advanced brain cancer.
From Risk to Resilience: Tracking a Genetic Variant's Impact on Kidney Diseases
African Americans are five times more likely to develop chronic kidney disease (CKD) than European Americans.
Bloomberg Grant Funds Innovative Partnership for Early College High School in Durham
A partnership between Duke Health, Durham Technical Community College and Durham Public Schools has been awarded a transformative $29.5 million grant from Bloomberg Philanthropies to establish an early college for high school students interested in pursuing health care careers upon graduation.
Survey Finds Link Between Drug/Cannabis Use During Pregnancy and Certain Childhood Cancers
While the risks of drug use, smoking and drinking during pregnancy are widely accepted, a new survey of parents has identified clear associations between certain types of childhood cancers and gestational substance use, notably cannabis.
Mary E. Klotman's Friday Message. A Look Back to Move Forward: A Year in Conversation
In this message, Dr. Klotman revisit some of the fascinating guests she interviewed during her Friday Messages of 2023. Their work attests to our commitment to education, research, patient care and community partnership. We have much to look forward to in 2024 and beyond.
Scales Named Associate Dean for Clinical Research Initiatives
Charles (Chuck) Scales, Jr, MD, MSHS, has been named associate dean for clinical research initiatives, effective immediately.
Traumatic Stress Associated With Smaller Brain Region
People with PTSD have a cerebellum about 2% smaller than unaffected adults, especially in areas that influence emotion and memory.
Breakthrough Genetic Sensor Lights up RNA Modifications in Real Time
Researchers at Duke University School of Medicine have unveiled a breakthrough genetic sensor that shines a light on critical changes in our genetic material.
Innovative Program Offers Specialized Care for Female Athletes
A unique multidisciplinary program established at Duke provides specialized care for women and girls involved in sports at every level, from professional athletes to recreational enthusiasts.
HIV Vaccine Takes Step Forward with Confirmation of Neutralizing Antibodies
A research team led by the Duke Human Vaccine Institute has activated specific immune cells that induce broadly neutralizing antibodies in a study using monkeys. The next phase of the work will now move to testing in humans.